METHOD OF TREATING DENGUE FEVER Russian patent published in 2016 - IPC A61K31/7068 A61K31/7072 A61K31/7076 A61K31/708 A61P31/12 C07H19/10 C07H19/20 

Abstract RU 2605904 C2

FIELD: chemistry.

SUBSTANCE: invention relates to compounds used in pharmaceutical compositions for treating diseases caused by dengue virus, having formulae: , where: R1 is aryl, where said aryl is phenyl or naphthyl, optionally substituted with one or three substitutes independently selected from a group consisting of following: C1-6alkoxy; R1a is C1-6alkyl; R1b is -OR1a or -N(R1a)2; R2a and R2b (i) are independently selected from a group consisting of following: hydrogen, C1-10alkyl, -(CH2)mC(=O)R1b and aryl-C1-3alkyl; R3 is C1-10alkyl or aryl-C1-3alkyl, where said aryl is phenyl; R4 is hydrogen; R6 is A, B, C or D, where R8 is hydrogen or C1-3alkyl; R5 and7 are independently selected from hydrogen, C(=O)C1-6alkyl; m ranges from 0 to 3; or its pharmaceutically acceptable salt.

EFFECT: treating diseases caused by dengue virus.

19 cl, 2 tbl, 2 ex

Similar patents RU2605904C2

Title Year Author Number
ALKYL2-{[(2R,3S,5R)-5-(4-AMINO-2-OXO-2H-PYRIMIDINE-1-YL)- -HYDROXY- TETRAHYDRO-FURAN-2-YLMETHOXY]-PHENOXY-PHOSPHORYLAMINO}-PROPTONATES, NUCLEOSIDE INHIBITORS OF RNA-POLYMERASE HCV NS5B, METHODS FOR PRODUCING AND USING THEM 2013
  • Ivashchenko Aleksandr Vasil'Evich
RU2534613C2
NUCLEOSIDE PHOSPHORAMIDATES AS ANTIVIRAL AGENTS 2008
  • Sofija Majkl Dzh.
  • Du Dzhinfa
  • Van Pejjujan'
  • Nagaratkhnam Dkhanapalan
RU2478104C2
SYNTHETIC INTERMEDIATE COMPOUND 1-(2-DESOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINE, SYNTHETIC INTERMEDIATE THIONUCLEOSIDES COMPOUND AND METHOD FOR THEIR PRODUCTION 2013
  • Nakamura Kouki
  • Simamura Satosi
  • Imoto Dzuniti
  • Takakhasi Motomasa
  • Vatanabe Katsuyuki
  • Vada Kendzi
  • Fudzino Yuuta
  • Matsumoto Takuya
  • Takakhasi Makoto
  • Okada Khideki
  • Yamane Takekhiro
  • Ito Takayuki
RU2633355C2
NEW METHOD FOR INHIBITION OF VIRUS GROWTH AND/OR VIRULICIDE METHOD AND NOVEL ANALOG OF PYRAZINE NUCLEOTIDE OR PYRAZINE NUCLEOSIDE 2002
  • Furuta Jusuke
  • Egava Khirojuki
  • Takakhasi Kazumi
  • Tsutsui Jasukhiro
  • Uekhara Sajuri
  • Murakami Makoto
RU2292894C2
ANTIVIRAL COMPOSITION AND METHOD OF ITS APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2650610C1
HCV-ACTIVE 4'-ASIDONUCLEOSIDES 2011
  • Ma Khan
  • Sarma Keshab
  • Smit Dehvid Bernard
RU2556991C2
NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2659388C1
COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE 2013
  • Kotian Pravin L.
  • Babu Yarlagadda S.
RU2654482C2
ANTI-RNA VIRAL, INCLUDING ANTI-CORONAVIRUS AGENT - SUBSTITUTED QUINOXALINE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS 2020
  • Ivashchenko Andrej Aleksandrovich
  • Ivashchenko Aleksandr Vasilevich
  • Savchuk Nikolaj Filippovich
  • Ivashchenko Alena Aleksandrovna
RU2744429C1
SUBSTITUTED (2R,3R,5R)-3-HYDROXY-(5-PYRIMIDIN-1-YL)TETRAHYDROFURAN-2-YLMETHYL ARYL PHOSPHORAMIDATES 2013
  • Ivashchenko Andrej Aleksandrovich
  • Ivashchenko Aleksandr Vasil'Evich
  • Mit'Kin Oleg Dmitrievich
RU2553996C1

RU 2 605 904 C2

Authors

Javanbakkht, Khassan

Klampp, Klaus

Zhen, Supin

Chzhan, Chzhumin

Dates

2016-12-27Published

2012-06-07Filed